6.
Pasquer A, Benech N, Pioche M, Breton A, Rivory J, Vinet O
. Prophylactic colectomy and rectal preservation in FAP: systematic endoscopic follow-up and adenoma destruction changes natural history of polyposis. Endosc Int Open. 2021; 9(7):E1014-E1022.
PMC: 8211478.
DOI: 10.1055/a-1467-6257.
View
7.
Al-Sukhni E, Shapiro J, Suraweera H, Semotiuk K, Swallow C, Brar S
. Desmoid Tumors in Familial Adenomatous Polyposis Patients: Favorable Outcomes with Multidisciplinary Management. Ann Surg Oncol. 2023; 30(8):5142-5149.
PMC: 10215061.
DOI: 10.1245/s10434-023-13675-1.
View
8.
Groen E, Roos A, Muntinghe F, Enting R, De Vries J, Kleibeuker J
. Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol. 2008; 15(9):2439-50.
PMC: 2518080.
DOI: 10.1245/s10434-008-9981-3.
View
9.
Gupta S, Provenzale D, Llor X, Halverson A, Grady W, Chung D
. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019. J Natl Compr Canc Netw. 2019; 17(9):1032-1041.
DOI: 10.6004/jnccn.2019.0044.
View
10.
Zaffaroni G, Mannucci A, Koskenvuo L, de Lacy B, Maffioli A, Bisseling T
. Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint.... Br J Surg. 2024; 111(5).
PMC: 11081080.
DOI: 10.1093/bjs/znae070.
View
11.
Kotiligam D, Lazar A, Pollock R, Lev D
. Desmoid tumor: a disease opportune for molecular insights. Histol Histopathol. 2007; 23(1):117-26.
DOI: 10.14670/HH-23.117.
View
12.
Sanchez-Mete L, Ferraresi V, Caterino M, Martayan A, Terrenato I, Mannisi E
. Desmoid Tumors Characteristics, Clinical Management, Active Surveillance, and Description of Our FAP Case Series. J Clin Med. 2020; 9(12).
PMC: 7764110.
DOI: 10.3390/jcm9124012.
View
13.
van Broekhoven D, Verhoef C, Elias S, Witkamp A, van Gorp J, van Geel B
. Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis. Br J Surg. 2013; 100(9):1214-9.
DOI: 10.1002/bjs.9194.
View
14.
Campos F, Martinez C, Bustamante-Lopez L, Mendonca R, Kanno D
. Intra-abdominal desmoid tumors in familial adenomatous polyposis: How much do clinical and surgical variables interfere with their development?. Clinics (Sao Paulo). 2022; 78:100144.
PMC: 9723922.
DOI: 10.1016/j.clinsp.2022.100144.
View
15.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J
. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24.
PMC: 4544753.
DOI: 10.1038/gim.2015.30.
View
16.
Kasper B, Baldini E, Bonvalot S, Callegaro D, Cardona K, Colombo C
. Current Management of Desmoid Tumors: A Review. JAMA Oncol. 2024; 10(8):1121-1128.
DOI: 10.1001/jamaoncol.2024.1805.
View
17.
Casali P, Abecassis N, Aro H, Bauer S, Biagini R, Bielack S
. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; 29(Suppl 4):iv51-iv67.
DOI: 10.1093/annonc/mdy096.
View
18.
Fiore M, Rimareix F, Mariani L, Domont J, Collini P, Le Pechoux C
. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol. 2009; 16(9):2587-93.
DOI: 10.1245/s10434-009-0586-2.
View
19.
Napolitano A, Provenzano S, Colombo C, Vitellaro M, Brunello A, Badalamenti G
. Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis. ESMO Open. 2020; 5(1).
PMC: 7003390.
DOI: 10.1136/esmoopen-2019-000604.
View
20.
Penel N, Cesne A, Bonvalot S, Giraud A, Bompas E, Rios M
. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group. Eur J Cancer. 2017; 83:125-131.
DOI: 10.1016/j.ejca.2017.06.017.
View